Clarivate (NYSE:CLVT) Shares Down 5.3% - Time to Sell?

Key Points

• Shares of Clarivate fell 5.3% to about $2.05 on Monday with volume ~2.06M (down 66% vs. average), trading well below its 50‑day ($3.21) and 200‑day ($3.65) moving averages; market cap is roughly $1.41B and the company posts a negative P/E (-3.74).
• Analyst sentiment is weak — Clarivate carries an average rating of "Reduce" with an average price target of $4.28, and recent downgrades/target cuts from Goldman Sachs and Morgan Stanley contrast with a lone upgrade from Wall Street Zen.
• Insider activity and ownership are notable: Bar Veinstein sold 309,902 shares at about $3.74 (reducing their position ~26.8%), while institutional investors own ~85.7% of the stock and several hedge funds materially increased holdings last quarter.

Shares of Clarivate PLC (NYSE:CLVT - Get Free Report) were down 5.3% on Monday . The company traded as low as $2.02 and last traded at $2.0450. Approximately 2,055,647 shares were traded during trading, a decline of 66% from the average daily volume of 6,130,213 shares. The stock had previously closed at $2.16.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Wall Street Zen raised shares of Clarivate from a "hold" rating to a "buy" rating in a research report on Saturday. The Goldman Sachs Group lowered shares of Clarivate from a "buy" rating to a "neutral" rating and decreased their price target for the company from $4.20 to $3.60 in a research note on Thursday, January 8th. Morgan Stanley reissued an "underweight" rating and set a $3.00 price target (down from $5.00) on shares of Clarivate in a report on Wednesday, December 17th. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of Clarivate in a research report on Monday, December 29th. Four analysts have rated the stock with a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Clarivate currently has an average rating of "Reduce" and an average price target of $4.28.

Clarivate Stock Down 1.4%

The firm has a 50 day simple moving average of $3.21 and a two-hundred day simple moving average of $3.65. The stock has a market capitalization of $1.41 billion, a P/E ratio of -3.74 and a beta of 1.51. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 0.90.

Insider Transactions at Clarivate

In related news, insider Bar Veinstein sold 309,902 shares of the stock in a transaction that occurred on Monday, December 1st. The shares were sold at an average price of $3.74, for a total value of $1,159,033.48. Following the completion of the transaction, the insider owned 848,811 shares of the company's stock, valued at $3,174,553.14. This represents a 26.75% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 23.18% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada boosted its stake in shares of Clarivate by 96.2% in the 1st quarter. Royal Bank of Canada now owns 63,630 shares of the company's stock valued at $250,000 after purchasing an additional 31,197 shares during the last quarter. AQR Capital Management LLC grew its holdings in Clarivate by 37.0% during the 1st quarter. AQR Capital Management LLC now owns 451,872 shares of the company's stock worth $1,749,000 after acquiring an additional 122,099 shares during the period. Millennium Management LLC raised its position in shares of Clarivate by 1,420.4% in the 1st quarter. Millennium Management LLC now owns 1,188,978 shares of the company's stock worth $4,673,000 after acquiring an additional 1,110,774 shares in the last quarter. Goldman Sachs Group Inc. lifted its stake in shares of Clarivate by 15.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 616,250 shares of the company's stock valued at $2,422,000 after purchasing an additional 82,768 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in shares of Clarivate by 13.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,243,683 shares of the company's stock worth $4,888,000 after buying an additional 144,462 shares in the last quarter. Institutional investors own 85.72% of the company's stock.

Clarivate Company Profile

Clarivate plc is a global information and analytics company that provides insights and workflow solutions to accelerate the pace of innovation. The company delivers proprietary data, analytics, and expertise to support research and development in the life sciences, intellectual property management, academic institutions, government agencies, and corporations. Its core offerings include citation and patent databases, drug pipeline analytics, trademark research tools, regulatory compliance solutions, and market intelligence platforms.

Originally part of Thomson Reuters' Intellectual Property & Science division, Clarivate was established as an independent entity in 2016 following a spin-off transaction.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.